T1	Participants 35 74	BRAF mutation in stage III colon cancer
T2	Participants 211 236	colorectal carcinogenesis
T4	Participants 448 484	patients with stage III colon cancer
T3	Participants 241 258	colorectal cancer
T5	Participants 561 596	506 stage III colon cancer patients
T6	Participants 1768 1790	stage III colon cancer
T7	Participants 1562 1597	patients with BRAF wild-type cancer
T8	Participants 1396 1429	patients with BRAF-mutated tumors
